Bharat Biotech’s COVAXIN Enters Phase 2 Of Human Trials
Sources confirmed that phase 2 of human trials for anti-coronavirus vaccine, COVAXIN, will begin in the first week of September.
Phase 2 human trials for Bharat Biotech anti-COVID-19 vaccine, COVAXIN will begin in September. News reports confirmed that phase 1 of the human trials in most centres has concluded successfully. India’s attempt to make a safe and efficient anti-coronavirus vaccine has finally seen some positive developments after COVAXIN cleared phase 1 of the human trials. Sources state that the centres are bracing for recruitment of candidates for phase 2 human trials which will begin in the first week of September.
The entire world has been struggling to fight the ongoing Coronavirus pandemic. Millions have been infected by the virus and a huge number of people across the world have lost their lives. India is currently one of the worst affected nations with thousands of cases increasing every day. However, the recovery rate in India has been impressive so far and now with COVAXIN entering phase 2 of human trials, India will definitely bounce back in this fight with COVID-19.
Catch the latest Coronavirus updates only on ZEE5